Oncology Practice Management seeks to offer process solutions for all members of the cancer care team—medical, surgical, and radiation oncologists, as well as executives, administrators, and coders/billers.
Updated ASCO Guidelines Reiterate the Importance of Geriatric Assessment in Older Patients with CancerThe American Society of Clinical Oncology (ASCO) has issued an update to its guidelines for the practical assessment and management of vulnerabilities in patients aged ≥65 years receiving systemic cancer treatment. The new recommendations, published in the Journal of Clinical Oncology, build on the Society’s previous guidance, published in 2018.
Generic and Biosimilar Drugs Generate $408 Billion in Savings for America’s Patients and Healthcare System in 2022Washington, DC—On September 6, 2023, the Association for Accessible Medicines, the leading trade association for generic and biosimilar manufacturers, released its 2023 U.S. Generic & Biosimilar Medicines Savings Report highlighting the value of generic and biosimilar medicines.
Philadelphia, PA—Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Top Trending Articles
Amgen offers assistance to patients through Amgen Assist 360, Amgen SupportPlus Co-Pay Program, and the Amgen Safety Net Foundation.
AstraZeneca, through its Access 360 and AZ&Me programs, offers a range of patient assistance to help streamline access and reimbursement for select AstraZeneca medicines.
Pfizer offers Pfizer Oncology Together, a patient support program to help patients access their prescribed Pfizer Oncology medications, identify financial assistance options, and connect patients to a dedicated Care Champion.
The Guide to Patient Support Services Index can be sorted by Drug or Company to help you quickly access information about programs offered by pharmaceutical companies and novel cancer drugs approved in 2022.